Quote:
Originally Posted by Almamida
2 - People with pre existing conditions are identified and known (They usually have health center / specialized clinics to deal with their conditions)
|
These specialized clinics would seem the ideal place to distribute vaccinations to the affected individuals, as long as there are enough qualifying patients available to make the difficult storage of Pfizer and Moderna feasible. I hope they are doing that at these clinics. The Johnson & Johnson vaccine may really change the landscape in regards to this however, with it's less stringent storage requirements. J&J may well open up lots of previously non-feasible locations to become distribution centers. I would support setting aside J&J vaccine to service people in special situations where it's storage benefits would really shine, and reserve Pfizer and Moderna for others who are more mobile, have fewer pre-existing conditions, etc. It seems that we have a natural division of vaccine recipients as well as a natural division of vaccines. That split was not intentionally created, but we should take advantage of it none-the-less.
Quote:
|
and prioritizing only based on age is clearly not the best solution.
|
Once again, I'll point out that I never said
only by age. I said
primarily by age, with tweaks to scheduling to account for other factors and conditions.